Ongoing Trials

FMT-Life is committed to advancing the field of Fecal Microbiota Transplantation (FMT) through innovative and impactful clinical trials. Our ongoing studies are designed to evaluate new applications of FMT, refine treatment protocols, and enhance patient outcomes. Below is an overview of our current trials and their objectives.

1. Overview of Ongoing Trials

1.1 Trial Objectives

• Objective: To investigate new therapeutic uses for FMT, optimize treatment protocols, and assess long-term efficacy and safety.

• Design: Multi-center randomized controlled trials, longitudinal studies, and exploratory research.

1.2 Areas of Focus

• Recurrent Clostridium difficile Infections (CDI)

• Irritable Bowel Syndrome (IBS)

• Inflammatory Bowel Disease (IBD)

• Novel Applications: Metabolic disorders, autoimmune diseases, and other chronic conditions.

2. Current Trials

2.1 Trial on FMT for Recurrent CDI

• Study Title: “Enhanced Fecal Microbiota Transplantation Techniques for Recurrent Clostridium difficile Infections”

• Objective: To compare traditional FMT methods with new, enhanced techniques to improve treatment outcomes and reduce recurrence rates.

• Status: Enrollment ongoing. Expected completion date: [Month, Year]

• Locations: [List of participating centers]

• Contact for Participation: [Email/Phone]

2.2 FMT in IBS Management

• Study Title: “Exploring FMT as a Treatment for Severe Irritable Bowel Syndrome: A Randomized Trial”

• Objective: To evaluate the efficacy of FMT in patients with severe IBS symptoms who have not responded to conventional therapies.

• Status: Enrollment ongoing. Expected completion date: [Month, Year]

• Locations: [List of participating centers]

• Contact for Participation: [Email/Phone]

2.3 FMT for Inflammatory Bowel Disease

• Study Title: “Fecal Microbiota Transplantation for Crohn’s Disease and Ulcerative Colitis: A Long-Term Study”

• Objective: To assess the long-term effects of FMT on disease activity, mucosal healing, and patient quality of life in IBD patients.

• Status: Enrollment ongoing. Expected completion date: [Month, Year]

• Locations: [List of participating centers]

• Contact for Participation: [Email/Phone]

2.4 Novel Applications of FMT

• Study Title: “Investigating the Potential of FMT in Metabolic Disorders and Autoimmune Diseases”

• Objective: To explore the efficacy of FMT in treating conditions such as obesity, type 2 diabetes, and autoimmune diseases.

• Status: Enrollment ongoing. Expected completion date: [Month, Year]

• Locations: [List of participating centers]

• Contact for Participation: [Email/Phone]

3. How to Participate

3.1 Eligibility Criteria

• Patients: Must meet specific inclusion and exclusion criteria for each trial. Detailed criteria are provided in the trial protocols.

• Physicians: Can refer eligible patients and participate in the trials as clinical investigators.

3.2 Enrollment Process

• For Patients: Consult with your healthcare provider to determine if you are eligible and to receive a referral.

• For Physicians: Contact us to learn about involvement opportunities and trial details.

4. Learn More About Ongoing Trials

4.1 Access Trial Information

• Detailed Protocols: Visit our Ongoing Trials page for comprehensive information on each study, including protocols, objectives, and enrollment details.

4.2 Stay Updated

• Subscribe: Sign up for our newsletter to receive updates on trial progress, new research opportunities, and study results.

5. Contact Us

For more information about our ongoing trials, to refer patients, or to get involved, please reach out to our research team:

• Email: research@fmt.life

• Phone: 617-575-2201

• Fax: 617-575-2201

We are dedicated to advancing FMT research and improving patient care through innovative clinical trials. Join us in our mission to explore new frontiers in microbiome-based therapies.